Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Conditions
- Acute Leukemia
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Lymphoma
- Chronic Myelogenous Leukemia
- Plasma Cell Leukemia
- Myeloproliferative Neoplasms
- Myelofibrosis
- Myelodysplasia
- Refractory Anemia
- High Risk Anemia
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Marginal Zone B-Cell Lymphoma
- Follicular Lymphoma
- Lymphoplasmacytic Lymphoma
- Mantle-Cell Lymphoma
- Prolymphocytic Leukemia
- Diffuse Large Cell Non Hodgkins Lymphoma
- Lymphoblastic Lymphoma
- Burkitt Lymphoma
- High Grade Non-Hodgkin's Lymphoma, Adult
- Multiple Myeloma
- Juvenile Myelomonocytic Leukemia
- Biphenotypic/Undifferentiated/Prolymphocytic Leukemias
- MRD Positive Leukemia
- Natural Killer Cell Malignancies
- Acquired Bone Marrow Failure Syndromes
Interventions
- BIOLOGICAL: HSCT with TBI Regimen
- BIOLOGICAL: HSCT with Non-TBI Regimen
Sponsor
Masonic Cancer Center, University of Minnesota